News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Advanced Biological Laboratories SA (ABL) Release: HepatiC™, HCV Patient Registry and Database to Aid in the Management of HCV-Infected Patients Receiving Direct Acting Antiviral Therapy



10/21/2013 9:51:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LUXEMBOURG--(BUSINESS WIRE)--Advanced Biological Laboratories (ABL) S.A. is pleased to announce the signing of a contract with the Spanish Association for the Study of the Liver (Asociación para el Estudio del Hídago, AEEH, www.aeeh.es) for the development and licensing of the new HepatiC™ software and database system. ABL undertakes the development, maintenance and upgrades and provides national access to the HepatiC™ program to the Spanish Community of Hepatologists to aid in the optimal personalized management of their HCV patients, especially those being treated with Direct Acting Antiviral (DAA) therapy.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES